$150.74 -2.94 (%) Intercept Pharmaceuticals Inc - NASDAQ

Apr. 29, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Keep an Eye on These 7 Stocks for February 16, 2016

    Benzinga | Feb. 16, 2016 | 04:22AM EST
  2. Benzinga's Weekend M&A Chatter

    Benzinga | Feb. 15, 2016 | 19:35PM EST
  3. Intercept Pharma Spikes On Report That It’s Exploring A Sale

    IBD | Feb. 12, 2016 | 15:30PM EST
  4. Intercept Pharmaceuticals Soars 30%; Reuters Reported Company Exploring A Potential Sale

    Benzinga | Feb. 12, 2016 | 13:43PM EST
  5. Benzinga's Top Upgrades

    Benzinga | Jan. 29, 2016 | 09:14AM EST
  6. BioMarin, Intercept hit by FDA

    IBD | Dec. 18, 2015 | 18:47PM EST
  7. BioMarin, Intercept Pharma Drugs Face FDA Delays

    IBD | Dec. 18, 2015 | 12:13PM EST
  8. INTERCEPT PHARMA

    IBD | Dec. 17, 2015 | 19:25PM EST
  9. Intercept Pharma Higher On Takeover Rumor

    Benzinga | Dec. 15, 2015 | 14:08PM EST
  10. Intercept Presents New Data Analyses on Non-Invasive Liver Testing From FLINT Trial of Obeticholic Acid in Nonalcoholic Steatohepatitis at AASLD 2015

    Benzinga | Nov. 15, 2015 | 09:59AM EST
  11. Intercept Presents New Primary Biliary Cholangitis Data at AASLD 2015

    Benzinga | Nov. 15, 2015 | 09:57AM EST
  12. Benzinga's M&A Chatter for Tuesday November 10, 2015

    Benzinga | Nov. 10, 2015 | 20:19PM EST
  13. Intercept Pharmaceuticals

    IBD | Oct. 28, 2015 | 18:47PM EST
  14. Intercept Pharmaceuticals Rebounds After Phase 2 Trial Of OCA Disappoints

    Benzinga | Oct. 28, 2015 | 16:15PM EST
  15. Intercept Pharma NASH Drug Disappoints In Japan

    IBD | Oct. 28, 2015 | 12:05PM EST
  16. Mid-Morning Market Update: Markets Open Higher; Hershey Earnings Beat Views

    Benzinga | Oct. 28, 2015 | 10:13AM EST
  17. Morning Market Losers

    Benzinga | Oct. 28, 2015 | 09:57AM EST
  18. Mid-Morning Market Update: Markets Open Lower; Carlyle Group To Acquire Blyth For $6/Share

    Benzinga | Aug. 31, 2015 | 10:22AM EST
  19. Morning Market Gainers

    Benzinga | Aug. 31, 2015 | 09:45AM EST
  20. FDA Grants Priority Review for Intercept's Obeticholic Acid for the Treatment of Primary Biliary Cirrhosis

    Benzinga | Aug. 31, 2015 | 07:05AM EST
  21. CNBC's Meg Tirrel Speculates About Gilead's New Acquisiton

    Benzinga | Jul. 10, 2015 | 06:52AM EST
  22. Sportsman's Warehouse, Bob Evans, Peabody Energy Lead Tuesday's After-Hours Movers

    Benzinga | Jun. 16, 2015 | 17:52PM EST
  23. Benzinga's Top Initiations

    Benzinga | May. 21, 2015 | 09:07AM EST
  24. Barclays Initiates Intercept Pharmaceuticals With Overweight

    Benzinga | May. 21, 2015 | 08:24AM EST
  25. Intercept Pharmaceuticals Inc (ICPT) Moves Forward With OCA REGENERATE Trial; Buy Why Did ...

    GuruFocus | May. 20, 2015 | 19:30PM EST
  26. Intercept has a design for test

    IBD | May. 19, 2015 | 18:30PM EST
  27. Intercept's NASH Trial Design Irks Investors

    IBD | May. 19, 2015 | 11:36AM EST
  28. Will The Bulls In Options Continue To Be Disappointed This Week?

    Benzinga | May. 18, 2015 | 14:17PM EST
  29. Analysts are Positive on Intercept Pharmaceuticals Inc Following Quarterly Earnings and ...

    GuruFocus | May. 12, 2015 | 16:30PM EST
  30. Earnings Scheduled For March 2, 2015

    Benzinga | Mar. 2, 2015 | 04:44AM EST
  31. Making Money With Charles Payne: 02/06/15

    FoxBusiness | Feb. 6, 2015 | 18:00PM EST
  32. Wedbush Highlights 2015 Catalysts for Emerging BioPharmaceuticals

    GuruFocus | Feb. 4, 2015 | 13:43PM EST
  33. Cowen And Company Analyst Explains Why Intercept Pharmaceuticals Is 'Absolutely A Buy'

    Benzinga | Feb. 2, 2015 | 08:00AM EST
  34. Cowen Analyst Likes Intercept Pharmaceuticals, ACADIA Pharmaceuticals And Raptor Pharmaceutical

    Benzinga | Feb. 1, 2015 | 12:54PM EST
  35. Mid-Afternoon Market Update: Crude Oil Jumps 7.5%; Visa Shares Climb On Earnings Beat

    Benzinga | Jan. 30, 2015 | 15:26PM EST
  36. Intercept Pharmaceuticals Soars 20%, Possible Short Squeeze

    Benzinga | Jan. 30, 2015 | 13:02PM EST
  37. Mid-Day Market Update: Amazon Jumps On Upbeat Earnings; Hawaiian Holdings Shares Slide

    Benzinga | Jan. 30, 2015 | 12:24PM EST
  38. Intercept Pharmaceuticals (ICPT) Obeticholic Acid Momentum, Gigamon (GIMO) Robust Revenue Growth

    GuruFocus | Jan. 30, 2015 | 11:09AM EST
  39. Benzinga's Volume Movers

    Benzinga | Jan. 30, 2015 | 10:44AM EST
  40. Mid-Morning Market Update: Markets Drop; Mastercard Profit Tops Expectations

    Benzinga | Jan. 30, 2015 | 10:42AM EST
  41. Morning Market Gainers

    Benzinga | Jan. 30, 2015 | 09:51AM EST
  42. Friday Morning Movers: Amazon Pops, Deckers Outdoor Plummets Following Earnings Results

    Benzinga | Jan. 30, 2015 | 09:27AM EST
  43. Stock Futures Sharpen Losses; Amazon, Visa, MasterCard Climb

    IBD | Jan. 30, 2015 | 09:01AM EST
  44. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 30, 2015 | 08:13AM EST
  45. INTERCEPT PHARMACEUTICALS

    IBD | Jan. 29, 2015 | 18:38PM EST
  46. Deutsche Bank: No Big Move In FY15 For Intercept Pharmaceuticals

    Benzinga | Jan. 22, 2015 | 13:38PM EST
  47. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 3

    Benzinga | Jan. 13, 2015 | 10:58AM EST
  48. Gilead Acquires Drug Program For Fatty Liver Disease

    IBD | Jan. 6, 2015 | 11:20AM EST
  49. IPO Stock Watch: FibroGen Up With Liver-Disease Field

    IBD | Jan. 5, 2015 | 16:40PM EST
  50. Making Money With Charles Payne: 12/22/14

    FoxBusiness | Dec. 22, 2014 | 18:00PM EST
Trading Center